Nephrocare Health Services IPO GMP: Day 1 IPO Live Updates

Posted by : sachet | Wed Dec 10 2025

The Nephrocare Health Services IPO GMP is ₹0 as of 10th December 2025. It is a bookbuilding IPO of ₹871.05 crores. This is an entirely fresh issue of 0.77 crore shares, and an offer for sale of 1.13 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 17th December 2025. The face value of Nephrocare Health Services IPO shares is ₹2 per share, and the IPO price band is ₹438 to ₹460 per share. Retail investors can bid for a minimum of 1 lot of 32 shares worth ₹14,720.

Table of Contents

Nephrocare Health Services IPO GMP Grey Market Premium

As mentioned earlier, the Nephrocare Health Services IPO GMP currently stands at ₹0 per share. Thus, the estimated listing price would be flat at ₹460. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for Riddhi Display Equipment IPO GMP updates.

GMP DATE	IPO Price	GMP Price	Estimated Listing Price	Estimated Gain
10-12-2025	₹460.00	₹0.00	₹460.00	0.00%
9-12-2025	₹460.00	₹0.00	₹460.00	0.00%
8-12-2025	₹460.00	₹0.00	₹460.00	0.00%
7-12-2025	₹460.00	₹0.00	₹460.00	0.00%
6-12-2025	₹460.00	₹0.00	₹460.00	0.00%
5-12-2025	₹460.00	₹0.00	₹460.00	0.00%
4-12-2025	₹460.00	₹0.00	₹460.00	0.00%
3-12-2025	₹460.00	₹0.00	₹460.00	0.00%
2-12-2025	₹460.00	₹0.00	₹460.00	0.00%

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Nephrocare Health Services IPO GMP status at Univest.

Nephrocare Health Services IPO Details

IPO Allotment Date	15th December 2025
IPO Open Date	10th December 2025
IPO Close Date	12th December 2025
Refund Initiation	16th December 2025
Issue Size	1,89,35,819 shares(aggregating up to ₹871.05 Cr)
Fresh Issue	76,82,717 shares(aggregating up to ₹353.40 Cr)
Offer for Sale	1,12,53,102 shares of ₹2(aggregating up to ₹517.64 Cr)
Face Value	₹2 per share
Lot Size	32 Shares
Issue Price	₹438 to ₹460 per share
Issue Type	Bookbuilding IPO
Listing At	BSE NSE
Listing Date	17th December 2025

Also Read: Nephrocare Health Services IPO GMP & Review: Apply or Avoid?

Explanation

Nephrocare Health Services IPO: Nephrocare Health Services IPO Limited has declared an issue price band of ₹438 to ₹460 per share. With this IPO, the company allows retail investors to bid for at least one lot of 32 shares, each worth ₹14,720. The face value of Nephrocare Health Services IPO Limited shares is ₹2 per share. The shares of Nephrocare Health Services IPO Limited will be listed on BSE and NSE on its tentative listing day, 17th December 2025. Scroll down to check GMP updates and Nephrocare Health Services IPO reviews.

Nephrocare Health Services IPO Objectives

The primary aim of the Nephrocare Health Services IPO is to raise ₹871.05 crores. On the other hand, Nephrocare Health Services has decided to utilise these funds in different ways.

To Capital expenditure by the Company for opening new dialysis clinics in India
To Pre-payment, or scheduled repayment, in whole or part, of certain borrowings availed by the Company
For general corporate purposes

Nephrocare Health Services IPO Registrar

Kfin Technologies Limited is the registrar for the Nephrocare Health Services IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Nephrocare Health Services allotment and refund, you can contact Kfin Technologies Limited at parkmedi.ipo@kfintech.com or at 0406716222 or 04079611000.

Nephrocare Health Services IPO Review

The Nephrocare Health Services IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Nephrocare Health Services Limited’s revenue increased by 34% from ₹574.72 crores in March 2024 to ₹769.92 crores in March 2025. Moreover, the company’s PAT increased by 91% from ₹35.13 crores in March 2024 to ₹67.10 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Nephrocare Health Services IPO or not.

Nephrocare Health Services IPO Technicals

Key Indicators	Value
PE Ratio (Price-to-Earnings)	63.52
EPS (Earnings Per Share)	7.24
RoNW	13.19%
ROCE	18.67%
ROE	13.45%
EBITDA Margin	22.05%
Price to Book Value	7.72
Market Capitalisation	₹4,615.34 Cr

The PE ratio of Nephrocare Health Services Limited shares is 63.52, and its Earnings Per Share (EPS) stands at 7.24. Thus, the Nephrocare Health Services IPO can deliver gains on its tentative listing date, 17th December 2025.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Nephrocare Health Services Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	63.52	162.19
EPS	7.24	2.84

FAQs on Nephrocare Health Services IPO

What is the Nephrocare Health Services IPO GMP?

Currently, on 10th December 2025, the Nephrocare Health Services IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹460 per share.

What is the issue price of Nephrocare Health Services IPO?

The Nephrocare Health Services IPO issue price band is set at ₹438.00 to ₹460.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 32 shares, worth ₹14,720. Moreover, HNIs are required to bid for a minimum of 14 lots (448 shares) worth ₹2,06,080.

Who is the registrar of the Nephrocare Health Services IPO?

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Nephrocare Health Services IPO, download the Nephrocare Health Services IPO RHP and Nephrocare Health Services IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.